NEU 1.52% $12.94 neuren pharmaceuticals limited

Share Price, page-8471

  1. 110 Posts.
    lightbulb Created with Sketch. 70
    You literally posted on the M&A (mergers &acquisitions) thread last night:

    "With regard to M&A, I thought the most telling remark from JP in the webinar today was in response to the following question.
    Question: Any comment on the commercialisation pathway for [NNZ in] PMS? JP: So we um… we said before the result that we expect to have lots of options, and obviously that’s absolutely the case now that we’ve got this result. But we haven’t made a decision yet, um regarding whether and when we’re going to partner.. um.. you know, we haven’t made a decision on that. We’ve still got to talk with the FDA, and test the partnering landscape.* We’ll update on that, in due course.*
    if "test the partnering landscape" isnt a euphamism for "Have BP representatives take a ticket, get in line, and show us the colour of their money" then I'll eat my hat."

    No euphemism at all. He's literally talking about whether NEU takes 2591 to Ph3 itself or partner's similar to what they did with trof.
    Nothing to do with TO offers. Where in that presentation yesterday did he even hint at TO offers?
 
watchlist Created with Sketch. Add NEU (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.